Related Experiment Video
Updated: Jun 13, 2026

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
Published on: March 21, 2013
[Clinical features and changes of 5-hydroxytryptamine in children with vasovagal syncope]
1Children's Hospital Affiliated to Capital Institute of Pediatrics, Beijing 100020, China.
Insights
Platelet 5-hydroxytryptamine (5-HT) levels were significantly elevated in children experiencing vasovagal syncope (VVS) during syncope and presyncope episodes. This suggests the central serotonergic system may play a role in the development of VVS in children.
Area of Science:
- Pediatrics
- Neuroscience
- Biochemistry
Context:
- Childhood vasovagal syncope (VVS) is a common condition.
- The role of 5-hydroxytryptamine (5-HT) in VVS pathogenesis is not fully understood.
- Previous studies have not conclusively linked plasma or platelet 5-HT levels to VVS in children.
Purpose:
- To investigate the clinical features of childhood VVS.
- To explore the relationship between plasma and platelet 5-HT levels and childhood VVS.
- To determine if 5-HT levels can predict syncope triggers.
Summary:
- Forty-one children diagnosed with VVS and 36 healthy children were studied.
- Clinical features and plasma/platelet 5-HT levels were measured using ELISA.
- While plasma 5-HT showed no significant changes, platelet 5-HT was significantly higher during syncope/presyncope in VVS patients.
Impact:
- Findings suggest that elevated platelet 5-HT during syncope/presyncope episodes may indicate central serotonergic system involvement in VVS pathogenesis.
- Plasma 5-HT levels do not appear to be a reliable predictor of syncope triggers in children.
- This research contributes to understanding the neurochemical underpinnings of VVS in pediatric populations.
Objective:
To investigate clinical features of childhood vasovagal syncope (VVS) and the possible relationship between changes of plasma and platelet 5-hydroxytryptamine (5-HT) and childhood VVS.
Method:
Forty-one children who were diagnosed as VVS because of positive head-up tilt test (HUTT) in Capital Institute of Pediatrics were enrolled as HUT-positive group, while 36 healthy children as control group. Clinical features of all children were analyzed, and blood samples of all children were obtained. Plasma and platelet 5-HT was measured by enzyme-linked immunosorbent assay (ELISA).
Result:
(1) The mean age of 41 VVS children was (10.5 +/- 1.8) years, and there were more girls than boys with the boys to girls ratio of 1:1.4. (2) Presyncopal symptoms occurred in 33 patients (80.4%), among whom dizziness had a high rate: 78.8%. (3) Commonly, there were some provocation factors before syncope, among which long-time standing was the most common one with the rate of 91.7%. (4) The mean time of positive response in BHUT and SNHUT were (20.6 +/- 8.6) minutes and (5.0 +/- 2.2) minutes, respectively. Duration of syncope was shorter than 5 minutes. (5) HUTT positive response included vasodepressor type with the rate of 61.0%, cardioinhibitory type with 14.6%, and mixed type with 24.4%. (6) There were no significant differences in baseline heart rate, systolic blood pressure and diastolic blood pressure between VVS children and healthy children. And it was the same among different types of VVS children. (7) There were no significant differences in plasma 5-HT between VVS group of baseline or HUTT-positive and control group [(27.51 +/- 1.32) microg/L vs.(27.28 +/- 2.48)microg/L, t = 0.518, P = 0.606; (27.51 +/- 1.32) microg/L vs.(28.05 +/- 1.40) microg/L, t = 2.044, P = 0.167]. There were no significant differences in platelet 5-HT concentration between VVS group of baseline and control group [(82.30 +/- 6.06) 10(9) ng/L vs. (79.88 +/- 5.79) 10(9) ng/L, t = 1.788, P = 0.780].(8) HUTT-positive platelet 5-HT concentration of VVS children was significantly higher than baseline value [(97.90 +/- 6.59) 10(9) ng/L vs. (82.30 +/- 6.06) 10(9) ng/L, t = 11.26, P = 0.00].
Conclusion:
There were no significant changes in plasma 5-HT in children with VVS during baseline, syncope or pre-syncope, which suggests that plasma 5-HT might not be valuable for the prediction of syncope trigger. However, platelet 5-HT of VVS children was obviously higher during syncope and presyncope, which suggests that central serotonergic system might be involved in the pathogenesis of VVS.
Related Concept Videos
Pathophysiology of Vomiting
Dysrhythmias III: Characteristics of Dysrhythmias
Toxidromes: Clinical Features
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with bradycardia...
Dysrhythmias II: Classification of Tachyarrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias

